CAPR
Capricor Therapeutics Inc
NASDAQ · Biotechnology
$24.72
+1.69 (+7.34%)
Open$23.36
Previous Close$23.03
Day High$25.21
Day Low$23.23
52W High$40.37
52W Low$4.30
Volume—
Avg Volume1.06M
Market Cap1.34B
P/E Ratio—
EPS$-1.80
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+152.6% upside
Current
$24.72
$24.72
Target
$62.44
$62.44
$34.96
$62.44 avg
$82.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 34.40M | 187.20M | 168.99M |
| Net Income | -62,506,501 | 36.18M | 32.84M |
| Profit Margin | -181.7% | 19.3% | 19.4% |
| EBITDA | -63,708,759 | 59.64M | 51.36M |
| Free Cash Flow | — | 19.67M | 27.43M |
| Rev Growth | +352.7% | +21.4% | +1.7% |
| Debt/Equity | 0.02 | 1.29 | 1.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |